Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma
Authors:
- L. KretschmerLKL. Kretschmer
- K. -P. PreuerKPK. -P. Preuer
- W. Ch. MarschWMW. Ch. Marsch
- C. NeumannCNC. Neumann
- 1 October 2000
- journal article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 10 (5) , 483-489
Abstract
To date, no study of melanoma patients who have undergone delayed lymph node dissection (DLND) has focused on the independent prognostic factors of overall survival, as calculated from surgery on the primary. Using Kaplan-Meier estimates and Cox's proportional hazard model, the significance of prognostic factors was evaluated in 173 patients who developed clinically apparent regional lymph node metastases. When calculated from excision of the primary tumour (median Breslow thickness 3.0 mm), the median survival was 38 months. When calculated from DLND, the median survival was 19 months. Multifactorial analysis revealed that the number of nodes involved at the time of DLND significantly affected both survival calculated from primary tumour excision (P = 0.0002) and survival calculated from DLND (P < 0.0001). In contrast, the well-known risk factors of primary melanoma did not significantly influence overall survival or survival after DLND. However, the remission duration between surgery on the primary and DLND clearly depended on epidermal ulceration (P = 0.001), Breslow thickness (P = 0.009) and the site of the primary melanoma (P = 0.048). Thus, in patients submitted to DLND, the risk factors of primary melanoma influence the early period of the disease, until metastatic lymph nodes become palpable. With regard to overall survival, only the extent of nodal disease determines the prognosis of these patients.Keywords
This publication has 20 references indexed in Scilit:
- Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.Journal of Clinical Oncology, 1998
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Introduction: Sentinel lymphadenectomy for patients with clinical stage I melanomaJournal of Surgical Oncology, 1997
- Efficacy of an Elective Regional Lymph Node Dissection of 1 to 4 mm Thick Melanomas for Patients 60 Years of Age and YoungerAnnals of Surgery, 1996
- The Orderly Progression of Melanoma Nodal MetastasesAnnals of Surgery, 1994
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Improved Long-term Survival After Lymphadenectomy of Melanoma Metastatic to Regional NodesAnnals of Surgery, 1991
- A Multifactorial Analysis of MelanomaAnnals of Surgery, 1981
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsNew England Journal of Medicine, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958